Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up

DNA methylation analysis of cervical scrapes using FAM19A4 and mir124‐2 genes has shown a good clinical performance in detecting cervical cancer and advanced CIN lesions in need of treatment in HPV‐positive women. To date, longitudinal data on the cancer risk of methylation test‐negative women are l...

Descripción completa

Detalles Bibliográficos
Autores principales: De Strooper, Lise M.A., Berkhof, Johannes, Steenbergen, Renske D.M., Lissenberg‐Witte, Birgit I., Snijders, Peter J.F., Meijer, Chris J.L.M., Heideman, Daniëlle A.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Cancer Therapy and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099282/
https://www.ncbi.nlm.nih.gov/pubmed/29663363
http://dx.doi.org/10.1002/ijc.31539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099282/
https://www.ncbi.nlm.nih.gov/pubmed/29663363
http://dx.doi.org/10.1002/ijc.31539

Ejemplares similares